Equity
€586,272 ▼ 32.3%
DR. NAIM JERJIR paid out €791,880 in dividends. That is 155% of the 2025 profit.
DR. NAIM JERJIR
Lifetime
6 annual accounts with figures on one time axispeak €694,331 (2025)
€694,331▲ 7.8%
peak €512,000 (2025)
€512,000▲ 6.6%
peak €1.1m (2023)
€586,272▼ 32.3%
€162,854▲ 141%
Board1 name since 2019
1 directorJERJIR Naïm
Documentsfilings and deeds
29-08-202629 days late
2025micro format
Purpose change 04-06Dividend €791,880Equity from €866,152 to €586,272Debts from €67,642 to €162,854Cash from €68,337 to €91,946
Key points
from the 2025 annual accountsTurnover
≈ €1.1m estimated
The micro format states no turnover.
Debts
€162,854 ▲ 141%
Debts rose by €95,212 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Liquidity
4.51 was 13.51 in 2024
Short-term debts rose from €67,642 to €162,854.
Filings
6 annual accounts 5 late
The 2020 accounts came latest: 111 days after the end of the period.
Position in the sector
€512,000
Higher net result than 95% of companies in human health. Sector median €60,073 · 20,761 companies.
Checked score
94
Excellent
Financially stronger than 53% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: 0.1%▲ +0.1 percentage points vs 07-2026highest value
09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
raises risk
1 change of registered office in 24 months
lowers risk
Sector: Human health activities (NACE 86)
Figures for financial year 2025 (filed on 29-08-2026)
Size: total assets €749,126
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 35% on liquidity, 80% on profitability and 17% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 6,782 companies had the same profile as DR. NAIM JERJIR has now. Each dot stands for 17 companies, two years later.
96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
That fits the bankruptcy probability of DR. NAIM JERJIR itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,782 companies, not a prediction for DR. NAIM JERJIR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €55,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.51 (13.51 in 2024), above the usual 1.5. Short-term debt is 21.7% and cash 12.3% of total assets. 21.7% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 29 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-08-2026, 29 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 6 filingsDeviation from the deadline
2025
29 days late
2024
on the day
2023
20 days late
2022
25 days late
2021
39 days late
2020
111 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 6 accounts on average 37 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 25 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered office moved from Antwerp to Nieuwkerken-Waas
New registered office: Jef De Pauwstraat 4, 9100 Nieuwkerken-Waas · Previous registered office: Belgiëlei 23 bus 901, 2018 Antwerpen · General meeting of 07-05-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0736461810
Purpose change
“De uitoefening van de geneeskunde door de geneesheer-aandeelhouder,specialisatie radiologie en medische…” (deed in Dutch) · General meeting of 09-05-2025 · Gazette deed
Amendment of the articles
“Deze opsomming is verklarend en niet beperkend en moet verstaan worden in de meest ruime zin; De vennootschap…” (deed in Dutch) · General meeting of 19-09-2023 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR. NAIM JERJIR Sint-Niklaas | €749,126 | €694,331 | 78.3% | - |
| ILEX Kortrijk | €763,415 | €669,843 | 29.1% | - |
| Ultraview Hasselt | €755,158 | €694,009 | 66.0% | - |
| Dr. Hans Van Der Meersch Bruges | €711,312 | €652,157 | 0.4% | - |
| DR PETRA NIJST - CARDIOLOGIE Lanaken | €777,462 | €698,057 | 64.9% | - |
| Dr. Vermander - Dr. Vandewalle Bruges | €739,949 | €657,321 | 64.9% | - |
| Eva Diltoer, oftalmoloog Kortenberg | €772,333 | €629,283 | 45.9% | 1.7 |
These companies have the same main activity as DR. NAIM JERJIR: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €711,000 and €777,000, founded between 2018 and 2020.
Official details
Source: KBO- Status
- Active since 16-10-2019Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.295.685.9342018 Antwerp, since 16-10-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 21-10-2026
Insights on DR. NAIM JERJIR
DR. NAIM JERJIR files the micro format. That format states no turnover. The gross margin rose from €342,193 in 2020 to €694,331 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR. NAIM JERJIR
- What is the company number of DR. NAIM JERJIR?
- The company number of DR. NAIM JERJIR is 0736.461.810. The VAT number is the same number with BE in front: BE 0736.461.810.
- Where is DR. NAIM JERJIR based?
- The registered office is at Jef De Pauwstraat 4, 9100 Sint-Niklaas.Company details
- What does DR. NAIM JERJIR do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DR. NAIM JERJIR?
- DR. NAIM JERJIR is a private limited company (BV).
- When was DR. NAIM JERJIR founded?
- DR. NAIM JERJIR was founded on 16-10-2019.
- Is DR. NAIM JERJIR still active?
- Yes, DR. NAIM JERJIR is an active enterprise in the KBO register.
- What is the turnover of DR. NAIM JERJIR?
- The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €694,331 and 30 comparable companies (NACE 86220). It probably lies between €940,000 and €1.5m.Financials
- Is DR. NAIM JERJIR profitable?
- In financial year 2025, DR. NAIM JERJIR made a profit of €512,000.
- Where can I find the annual accounts of DR. NAIM JERJIR?
- DR. NAIM JERJIR filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR. NAIM JERJIR due?
- DR. NAIM JERJIR must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.